B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance
Jang‐June Park(Walther Cancer Foundation), Koji Tamada(Yamaguchi University), Atsuo Kuramasu(Showa University), Ryusuke Omiya(The University of Osaka), Yumiko Matsumura(Kyushu University), Yukimi Sakoda(Yamaguchi University), Scott E. Strome(Northwestern Medicine Lake Forest Hospital), Lieping Chen(Yale Cancer Center), Sheng Yao(BioReliance (United States)), Yingjia Liu(University of Science and Technology of China), Sudarshan Anand(Cancer Institute (WIA)), Hidehiko Narazaki(Johns Hopkins University), Mathew M. Augustine(Southwestern Medical Center), Fumihiko Tsushima(Johns Hopkins University)
Cited by 323
Related Papers
Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
|New England Journal of Medicine|2012|12.6k
Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion
|Nature Medicine|2002|5.1k
Anti–PD-1/PD-L1 therapy of human cancer: past, present, and future
|Journal of Clinical Investigation|2015|1.4k
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
|Nature Immunology|2001|1k
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target
|Proceedings of the National Academy of Sciences|2004|767